127 related articles for article (PubMed ID: 38876822)
21. The Pitt-Hopkins syndrome: report of 16 new patients and clinical diagnostic criteria.
Marangi G; Ricciardi S; Orteschi D; Lattante S; Murdolo M; Dallapiccola B; Biscione C; Lecce R; Chiurazzi P; Romano C; Greco D; Pettinato R; Sorge G; Pantaleoni C; Alfei E; Toldo I; Magnani C; Bonanni P; Martinez F; Serra G; Battaglia D; Lettori D; Vasco G; Baroncini A; Daolio C; Zollino M
Am J Med Genet A; 2011 Jul; 155A(7):1536-45. PubMed ID: 21671391
[TBL] [Abstract][Full Text] [Related]
22. Fatal gastrointestinal complications in Pitt-Hopkins syndrome.
Koppen IJN; Menke LA; Westra WM; Struik F; Mesman S; van Wijk MP; Huisman SA
Am J Med Genet A; 2023 Mar; 191(3):855-858. PubMed ID: 36511359
[TBL] [Abstract][Full Text] [Related]
23. MeCP2 deficiency is associated with reduced levels of tubulin acetylation and can be restored using HDAC6 inhibitors.
Gold WA; Lacina TA; Cantrill LC; Christodoulou J
J Mol Med (Berl); 2015 Jan; 93(1):63-72. PubMed ID: 25209898
[TBL] [Abstract][Full Text] [Related]
24. JNK signaling provides a novel therapeutic target for Rett syndrome.
Musi CA; Castaldo AM; Valsecchi AE; Cimini S; Morello N; Pizzo R; Renieri A; Meloni I; Bonati M; Giustetto M; Borsello T
BMC Biol; 2021 Dec; 19(1):256. PubMed ID: 34911542
[TBL] [Abstract][Full Text] [Related]
25. Development of a Novel AAV Gene Therapy Cassette with Improved Safety Features and Efficacy in a Mouse Model of Rett Syndrome.
Gadalla KKE; Vudhironarit T; Hector RD; Sinnett S; Bahey NG; Bailey MES; Gray SJ; Cobb SR
Mol Ther Methods Clin Dev; 2017 Jun; 5():180-190. PubMed ID: 28497075
[TBL] [Abstract][Full Text] [Related]
26. Recent endeavors in MECP2 gene transfer for gene therapy of Rett syndrome.
Sinnett SE; Gray SJ
Discov Med; 2017 Oct; 24(132):153-159. PubMed ID: 29272692
[TBL] [Abstract][Full Text] [Related]
27. Molecular and Cellular Function of Transcription Factor 4 in Pitt-Hopkins Syndrome.
Chen HY; Bohlen JF; Maher BJ
Dev Neurosci; 2021; 43(3-4):159-167. PubMed ID: 34134113
[TBL] [Abstract][Full Text] [Related]
28. Rett syndrome: the complex nature of a monogenic disease.
Renieri A; Meloni I; Longo I; Ariani F; Mari F; Pescucci C; Cambi F
J Mol Med (Berl); 2003 Jun; 81(6):346-54. PubMed ID: 12750821
[TBL] [Abstract][Full Text] [Related]
29. Vitamin D modulates cortical transcriptome and behavioral phenotypes in an Mecp2 heterozygous Rett syndrome mouse model.
Ribeiro MC; MacDonald JL
Neurobiol Dis; 2022 Apr; 165():105636. PubMed ID: 35091041
[TBL] [Abstract][Full Text] [Related]
30. The recurrent TCF4 missense variant p.(Arg389Cys) causes a neurodevelopmental disorder overlapping with but not typical for Pitt-Hopkins syndrome.
Popp B; Bienvenu T; Giurgea I; Metreau J; Kraus C; Reis A; Fischer J; Bralo MP; Tenorio-Castaño J; Lapunzina P; Almoguera B; Lopez-Grondona F; Sticht H; Zweier C
Clin Genet; 2022 Dec; 102(6):517-523. PubMed ID: 35908153
[TBL] [Abstract][Full Text] [Related]
31. Introducing Pitt-Hopkins syndrome-associated mutations of TCF4 to Drosophila daughterless.
Tamberg L; Sepp M; Timmusk T; Palgi M
Biol Open; 2015 Nov; 4(12):1762-71. PubMed ID: 26621827
[TBL] [Abstract][Full Text] [Related]
32. Improved survival and reduced phenotypic severity following AAV9/MECP2 gene transfer to neonatal and juvenile male Mecp2 knockout mice.
Gadalla KK; Bailey ME; Spike RC; Ross PD; Woodard KT; Kalburgi SN; Bachaboina L; Deng JV; West AE; Samulski RJ; Gray SJ; Cobb SR
Mol Ther; 2013 Jan; 21(1):18-30. PubMed ID: 23011033
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of Na
Martinowich K; Das D; Sripathy SR; Mai Y; Kenney RF; Maher BJ
Mol Psychiatry; 2023 Jan; 28(1):76-82. PubMed ID: 36224259
[TBL] [Abstract][Full Text] [Related]
34. TCF4 Mutations Disrupt Synaptic Function Through Dysregulation of RIMBP2 in Patient-Derived Cortical Neurons.
Davis BA; Chen HY; Ye Z; Ostlund I; Tippani M; Das D; Sripathy SR; Wang Y; Martin JM; Shim G; Panchwagh NM; Moses RL; Farinelli F; Bohlen JF; Li M; Luikart BW; Jaffe AE; Maher BJ
Biol Psychiatry; 2024 Apr; 95(7):662-675. PubMed ID: 37573005
[TBL] [Abstract][Full Text] [Related]
35. Defects in brainstem neurons associated with breathing and motor function in the Mecp2R168X/Y mouse model of Rett syndrome.
Johnson CM; Zhong W; Cui N; Wu Y; Xing H; Zhang S; Jiang C
Am J Physiol Cell Physiol; 2016 Dec; 311(6):C895-C909. PubMed ID: 27653984
[TBL] [Abstract][Full Text] [Related]
36. Generation of 10 patient-specific induced pluripotent stem cells (iPSCs) to model Pitt-Hopkins Syndrome.
Sripathy SR; Wang Y; Moses RL; Fatemi A; Batista DA; Maher BJ
Stem Cell Res; 2020 Oct; 48():102001. PubMed ID: 32971458
[TBL] [Abstract][Full Text] [Related]
37. Langerhans cell histiocytosis in a young patient with Pitt-Hopkins syndrome.
Macchiaiolo M; Panfili FM; Gonfiantini MV; Mastrogiorgio G; Buonuomo PS; Gaspari S; Longo D; Zollino M; Bartuli A
Am J Med Genet A; 2020 Nov; 182(11):2746-2750. PubMed ID: 32945094
[TBL] [Abstract][Full Text] [Related]
38. Transcription factor 4 and myocyte enhancer factor 2C mutations are not common causes of Rett syndrome.
Armani R; Archer H; Clarke A; Vasudevan P; Zweier C; Ho G; Williamson S; Cloosterman D; Yang N; Christodoulou J
Am J Med Genet A; 2012 Apr; 158A(4):713-9. PubMed ID: 22383159
[TBL] [Abstract][Full Text] [Related]
39. Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation.
Cheung AY; Horvath LM; Grafodatskaya D; Pasceri P; Weksberg R; Hotta A; Carrel L; Ellis J
Hum Mol Genet; 2011 Jun; 20(11):2103-15. PubMed ID: 21372149
[TBL] [Abstract][Full Text] [Related]
40. Treatment with the Bacterial Toxin CNF1 Selectively Rescues Cognitive and Brain Mitochondrial Deficits in a Female Mouse Model of Rett Syndrome Carrying a MeCP2-Null Mutation.
Urbinati C; Cosentino L; Germinario EAP; Valenti D; Vigli D; Ricceri L; Laviola G; Fiorentini C; Vacca RA; Fabbri A; De Filippis B
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
